BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10606817)

  • 1. Multiple mutations of the p53 gene in human mammary carcinoma.
    Meng L; Lin L; Zhang H; Nassiri M; Morales AR; Nadji M
    Mutat Res; 1999 Dec; 435(3):263-9. PubMed ID: 10606817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
    Meng L; Lin L; Fresno M; Morales AR; Nadji M
    Int J Oncol; 1999 Sep; 15(3):555-8. PubMed ID: 10427139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
    J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of p53 tumor suppressor gene mutations and breast cancer survival.
    Lai H; Ma F; Trapido E; Meng L; Lai S
    Breast Cancer Res Treat; 2004 Jan; 83(1):57-66. PubMed ID: 14997055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Mutation analysis in breast tumors by a DNA microarray method.
    Tennis M; Krishnan S; Bonner M; Ambrosone CB; Vena JE; Moysich K; Swede H; McCann S; Hall P; Shields PG; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):80-5. PubMed ID: 16434591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.
    Sommer SS; Cunningham J; McGovern RM; Saitoh S; Schroeder JJ; Wold LE; Kovach JS
    J Natl Cancer Inst; 1992 Feb; 84(4):246-52. PubMed ID: 1734086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors.
    Kandioler D; Dekan G; End A; Pasching E; Buchmayer H; Gnant M; Langmann F; Mannhalter C; Eckersberger F; Wolner E
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):827-31; discussion 832. PubMed ID: 8614143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index.
    Merlo GR; Bernardi A; Diella F; Venesio T; Cappa AP; Callahan R; Liscia DS
    Int J Cancer; 1993 Jun; 54(4):531-5. PubMed ID: 8514444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
    Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
    Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
    J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
    Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
    Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
    Soong R; Iacopetta BJ
    Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
    Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.